Aldosterone increases vascular calcification in "in vitro" studies;La aldosterona aumenta la calcificación vascular in vitro

Nefrologia

Volumn 28, Issue 2, 2008, Pages 224-225

  De Solis A J ^a   Gonzalez Pacheco F R ^a   Deudero, J J P ^a,b   Neria, F ^a   Calabia, O ^a   Fernandez Sanchez R ^a   Caramelo, C ^a  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN JIMÉNEZ DÍAZ   (Spain)

^b Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 51149119530     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (12)

1. Mori K, Shioi A, Jono S, Nishizawa Y, Morii H. Expression of matrix Gla protein (MGP) in an in vitro model of vascular calcification. FEBS Lett 1998; 433 (1-2): 19-22.
2. Proudfoot D, Skepper JN, Shanahan CM, Weissberg PL. Calcification of human vascular cells in vitro is correlated with high levels of matrix Gla protein and low levels of osteopontin expression. Arterioscler Thromb Vasc Biol 1998; 18 (3): 379-388.
3. Wallin R, Wajih N, Greenwood GT, Sane DC. Arterial calcification: a review of mechanisms, animal models, and the prospects for therapy. Med Res Rev 2001; 21 (4): 274-301.
4. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Pérez A y cols. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999; 341 (10): 709-717.
5. Jiang G, Cobbs S, Klein JD, O'Neill WC. Aldosterone regulates the Na-K-2Cl co-transporter in vascular smooth muscle. Hypertension 2003; 41 (5): 1131-1135.
6. Mazak I, Fiebeler A, Muller DN, Park JK, Shagdarsuren E, Lindschau C y cols. Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells. Circulation 2004; 109 (22): 2792-2800.
7. Mironneau J. Calcium channel antagonist effects of spironolactone, an aldosterone antagonist. Am J Cardiol 1990; 65 (23): 7K-8K.
8. Campbell JH, Campbell GR. Culture techniques and their applications to studies of vascular smooth muscle. Clin Sci (Lond) 1993; 85 (5): 501-513.
9. De Solís AJ, González-Pacheco FR, Deudero JJ, Castilla MA, Neria F, Peñate S y cols. Uremic and bicarbonate concentration effects on vascular smooth muscle cells calcification: role of transporters. Nefrología 2005; XXV [3]: 7.
10. Jaffe IZ, Tintut Y, Newfell BG, Demer LL, Mendelsohn ME. Mineralocorticoid receptor activation promotes vascular cell calcification. Arterioscler Thromb Vasc Biol 2007; 27 (4): 799-805.
11. Bourcier T, Blain P, Massin P, Grunfeld JP, Gaudric A. Sclerochoroidal calcification associated with Gitelman syndrome. Am J Ophthalmol 1999; 128 (6): 767-768.
12. García N, V, Cantabrana A, Muller D, Claverie-Martin F. [Chondrocalcinosis and hypomagnesaemia in a patient with a new mutation in the gene of the thiazide-sensitive Na-Cl cotransporter]. Nefrologia 2003; 23 (6): 504-509.